Skip to main content
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 1997;24(3):173–178.

Predictors of primary patency failure in Wallstent self-expanding endovascular prostheses for iliofemoral occlusive disease.

S Damaraju 1, L Cuasay 1, D Le 1, N Strickman 1, Z Krajcer 1
PMCID: PMC325439  PMID: 9339504

Abstract

We studied the factors that affected the primary patency and the clinical and procedural success of WALLSTENTS (stents) that were used at our institution from 1 March 1994 to 30 October 1995 for the treatment of iliac and femoral artery occlusive disease. This prospective study comprised 63 patients with 82 lesions. Follow-up was performed for a mean duration of 18.7 months. Pre- and post-procedural duplex ultrasonography, together with estimation of ankle-brachial index scores, was performed on all patients, and additional studies were performed at clinical follow-up if indicated. The technical success rate was 100%. Ankle-brachial index scores improved considerably from 0.52 +/- 0.21 before the procedure to 0.73 +/- 0.27 after the procedure. The significant predictors by univariate analysis of primary patency failure were: Fontaine class III or IV (P = 0.044); femoral location (P = 0.004); lesion length > 100 mm (P = 0.010); poor or moderate outflow (P = 0.026); and number of stents > or = 3 (P = 0.012). Cox regression analysis showed that > or = 3 stents (risk ratio = 5.61), poor or moderate outflow (risk ratio = 6.05), and femoral location (risk ratio = 5.18) were the significant predictors of primary patency failure. Femoral lesions required more stents than did iliac lesions (2.2 +/- 0.8 vs 1.3 +/- 0.5). Primary patency rates for iliac and femoral stents were 86% and 49%, respectively, at 12 months, and 82% and 41% at 24 months.

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dyet J. F., Shaw J. W., Cook A. M., Nicholson A. A. The use of the Wallstent in aorto-iliac vascular disease. Clin Radiol. 1993 Oct;48(4):227–231. doi: 10.1016/s0009-9260(05)80301-0. [DOI] [PubMed] [Google Scholar]
  2. Hausegger K. A., Lammer J., Hagen B., Flückiger F., Lafer M., Klein G. E., Pilger E. Iliac artery stenting--clinical experience with the Palmaz stent, Wallstent, and Strecker stent. Acta Radiol. 1992 Jul;33(4):292–296. [PubMed] [Google Scholar]
  3. Long A. L., Page P. E., Raynaud A. C., Beyssen B. M., Fiessinger J. N., Ducimetière P., Relland J. Y., Gaux J. C. Percutaneous iliac artery stent: angiographic long-term follow-up. Radiology. 1991 Sep;180(3):771–778. doi: 10.1148/radiology.180.3.1831274. [DOI] [PubMed] [Google Scholar]
  4. Raillat C., Rousseau H., Joffre F., Roux D. Treatment of iliac artery stenoses with the Wallstent endoprosthesis. AJR Am J Roentgenol. 1990 Mar;154(3):613–616. doi: 10.2214/ajr.154.3.2106229. [DOI] [PubMed] [Google Scholar]
  5. Rutherford R. B., Becker G. J. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease. Radiology. 1991 Oct;181(1):277–281. doi: 10.1148/radiology.181.1.1887047. [DOI] [PubMed] [Google Scholar]
  6. Sapoval M. R., Chatellier G., Long A. L., Rovani C., Pagny J. Y., Raynaud A. C., Beyssen B. M., Gaux J. C. Self-expandable stents for the treatment of iliac artery obstructive lesions: long-term success and prognostic factors. AJR Am J Roentgenol. 1996 May;166(5):1173–1179. doi: 10.2214/ajr.166.5.8615265. [DOI] [PubMed] [Google Scholar]
  7. Vorwerk D., Guenther R. W. Mechanical revascularization of occluded iliac arteries with use of self-expandable endoprostheses. Radiology. 1990 May;175(2):411–415. doi: 10.1148/radiology.175.2.2139231. [DOI] [PubMed] [Google Scholar]
  8. Vorwerk D., Günther R. W. Stent placement in iliac arterial lesions: three years of clinical experience with the Wallstent. Cardiovasc Intervent Radiol. 1992 Sep-Oct;15(5):285–290. doi: 10.1007/BF02733952. [DOI] [PubMed] [Google Scholar]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES